McGowan Institute will co-direct $75 million second phase of national effort to aid wounded warriors

The Armed Forces Institute for Regenerative Medicine (AFIRM) will continue its efforts to apply the latest in tissue engineering and other regenerative medicine techniques to the treatment of battlefield injuries in a $75 million, five-year second phase.The AFIRM-II consortium of more than 30 academic centers and industry partners will be led by Anthony Atala, M.D.